BACKGROUND: Although plasma free fatty acid (FFA) concentrations have been associated with lipotoxicity, apoptosis, and risk of diabetes mellitus and coronary heart disease, it is unclear whether FFA levels are associated with heart failure (HF). METHODS AND RESULTS: To test the hypothesis that plasma concentration of FFAs is positively associated with incident HF, we prospectively analyzed data on 4248 men and women free of HF at baseline and >65 years old from the Cardiovascular Health Study. FFA concentration was measured in duplicate by the Wako enzymatic method. Incident HF was validated by a centralized Events Committee. We used Cox proportional hazards to estimate the hazard ratio of HF per SD of FFAs. During a median follow-up of 10.5 years, a total of 1286 new cases of HF occurred. In a multivariable model adjusting for clinic site, comorbidity, demographic, anthropometric, and lifestyle factors, each SD (0.2 mEq/L) higher plasma FFA was associated with 12% (95% confidence interval, 6%-19%) higher risk of HF. Controlling for time-varying diabetes mellitus and coronary heart disease did not change the results (hazard ratio per SD, 1.16 [95% confidence interval, 1.09-1.23]). CONCLUSIONS: A single measure of plasma FFA obtained later in life is associated with a higher risk of HF in older adults. Additional studies are needed to explore biological mechanisms by which FFAs may influence the risk of HF and determine whether FFAs could serve as a novel pharmacological target for HF prevention.
BACKGROUND: Although plasma free fatty acid (FFA) concentrations have been associated with lipotoxicity, apoptosis, and risk of diabetes mellitus and coronary heart disease, it is unclear whether FFA levels are associated with heart failure (HF). METHODS AND RESULTS: To test the hypothesis that plasma concentration of FFAs is positively associated with incident HF, we prospectively analyzed data on 4248 men and women free of HF at baseline and >65 years old from the Cardiovascular Health Study. FFA concentration was measured in duplicate by the Wako enzymatic method. Incident HF was validated by a centralized Events Committee. We used Cox proportional hazards to estimate the hazard ratio of HF per SD of FFAs. During a median follow-up of 10.5 years, a total of 1286 new cases of HF occurred. In a multivariable model adjusting for clinic site, comorbidity, demographic, anthropometric, and lifestyle factors, each SD (0.2 mEq/L) higher plasma FFA was associated with 12% (95% confidence interval, 6%-19%) higher risk of HF. Controlling for time-varying diabetes mellitus and coronary heart disease did not change the results (hazard ratio per SD, 1.16 [95% confidence interval, 1.09-1.23]). CONCLUSIONS: A single measure of plasma FFA obtained later in life is associated with a higher risk of HF in older adults. Additional studies are needed to explore biological mechanisms by which FFAs may influence the risk of HF and determine whether FFAs could serve as a novel pharmacological target for HF prevention.
Authors: H O Steinberg; M Tarshoby; R Monestel; G Hook; J Cronin; A Johnson; B Bayazeed; A D Baron Journal: J Clin Invest Date: 1997-09-01 Impact factor: 14.808
Authors: M A Charles; E Eschwège; N Thibult; J R Claude; J M Warnet; G E Rosselin; J Girard; B Balkau Journal: Diabetologia Date: 1997-09 Impact factor: 10.122
Authors: Robert J Goldberg; Karen Glatfelter; Emma Burbank-Schmidt; Cheryl Farmer; Frederick A Spencer; Theo Meyer Journal: Am J Cardiol Date: 2005-06-01 Impact factor: 2.778
Authors: B Hufnagel; M Dworak; M Soufi; Z Mester; Y Zhu; J R Schaefer; S Klumpp; J Krieglstein Journal: Atherosclerosis Date: 2005-01-26 Impact factor: 5.162
Authors: A Fagot-Campagna; B Balkau; D Simon; J M Warnet; J R Claude; P Ducimetière; E Eschwège Journal: Int J Epidemiol Date: 1998-10 Impact factor: 7.196
Authors: Sonali S Patel; Uyen Truong; Martina King; Annie Ferland; Kerrie L Moreau; Jennifer Dorosz; John E Hokanson; Hong Wang; Gregory L Kinney; David M Maahs; Robert H Eckel; Kristen J Nadeau; Melanie Cree-Green Journal: Vasc Med Date: 2017-01-17 Impact factor: 3.239
Authors: Paul N Black; Constance Ahowesso; David Montefusco; Nipun Saini; Concetta C DiRusso Journal: Medchemcomm Date: 2016-02-19 Impact factor: 3.597
Authors: Peter Ahiawodzi; Luc Djousse; Joachim H Ix; Jorge R Kizer; Russell P Tracy; Alice Arnold; Anne Newman; Kenneth J Mukamal Journal: J Am Geriatr Soc Date: 2020-09-22 Impact factor: 5.562
Authors: Luc Djousse; Mary L Biggs; Nirupa R Matthan; Joachim H Ix; Annette L Fitzpatrick; Irena King; Rozenn N Lemaitre; Barbara McKnight; Jorge R Kizer; Alice H Lichtenstein; Kenneth J Mukamal; David S Siscovick Journal: Cardiology Date: 2021-02-25 Impact factor: 1.869